Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9210039rdf:typepubmed:Citationlld:pubmed
pubmed-article:9210039lifeskim:mentionsumls-concept:C0085294lld:lifeskim
pubmed-article:9210039lifeskim:mentionsumls-concept:C0014834lld:lifeskim
pubmed-article:9210039lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:9210039lifeskim:mentionsumls-concept:C0003316lld:lifeskim
pubmed-article:9210039lifeskim:mentionsumls-concept:C0332157lld:lifeskim
pubmed-article:9210039lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:9210039lifeskim:mentionsumls-concept:C0079941lld:lifeskim
pubmed-article:9210039lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:9210039lifeskim:mentionsumls-concept:C1555580lld:lifeskim
pubmed-article:9210039pubmed:issue3lld:pubmed
pubmed-article:9210039pubmed:dateCreated1997-9-4lld:pubmed
pubmed-article:9210039pubmed:abstractTextWe constructed a panel of overlapping and non-overlapping fragments of cDNA derived from open reading frame 2 (ORF2) of hepatitis E virus (HEV) and fused to the gene encoding glutathione S-transferase (GST), from which proteins were expressed in Escherichia coli. IgG-specific immunoreactivity against each protein was measured by Western immunoblotting using sera from experimentally infected Rhesus macaques (Macaca mulatta) or from HEV-infected patients. Under these conditions, full-length ORF2 protein (GST-ORF2) was strongly reactive with acute-phase sera from either macaques or patients, but was poorly reactive with convalescent sera. Recombinant protein GST-ORF2.3, representing amino acids 1-110 of the 660 encoded by ORF2, demonstrated a pattern of reactivity largely indistinguishable from the full-length protein. Conversely, GST-ORF2.1, representing amino acids 394-660 of the ORF2 protein was strongly reactive with both acute- and convalescent-phase sera. Extension of GST-ORF2.1 towards the N-terminus led to a progressive loss of convalescent-phase reactivity, apparent with as few as 20 additional HEV-specific amino acids. Deletion of 40 or more amino acids from the N-terminus of ORF2.1 also led to reduced convalescent-phase reactivity, however a protein representing this "reactive" region, containing amino acids 394-473, was poorly reactive, suggesting that the convalescent-reactive epitopes are conformational. Expression of full-length ORF2 protein in E. coli therefore masks the convalescent-reactive epitopes within the C-terminal part of the protein, without affecting N-terminal, acute-reactive epitopes.lld:pubmed
pubmed-article:9210039pubmed:languageenglld:pubmed
pubmed-article:9210039pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9210039pubmed:citationSubsetIMlld:pubmed
pubmed-article:9210039pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9210039pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9210039pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9210039pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9210039pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9210039pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9210039pubmed:statusMEDLINElld:pubmed
pubmed-article:9210039pubmed:monthJullld:pubmed
pubmed-article:9210039pubmed:issn0146-6615lld:pubmed
pubmed-article:9210039pubmed:authorpubmed-author:GuyRRlld:pubmed
pubmed-article:9210039pubmed:authorpubmed-author:LocarniniS...lld:pubmed
pubmed-article:9210039pubmed:authorpubmed-author:AndersonD ADAlld:pubmed
pubmed-article:9210039pubmed:authorpubmed-author:LiFFlld:pubmed
pubmed-article:9210039pubmed:authorpubmed-author:ZhuWWlld:pubmed
pubmed-article:9210039pubmed:authorpubmed-author:ZhuangHHlld:pubmed
pubmed-article:9210039pubmed:authorpubmed-author:TorresiJJlld:pubmed
pubmed-article:9210039pubmed:issnTypePrintlld:pubmed
pubmed-article:9210039pubmed:volume52lld:pubmed
pubmed-article:9210039pubmed:ownerNLMlld:pubmed
pubmed-article:9210039pubmed:authorsCompleteYlld:pubmed
pubmed-article:9210039pubmed:pagination289-300lld:pubmed
pubmed-article:9210039pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9210039pubmed:meshHeadingpubmed-meshheading:9210039-...lld:pubmed
pubmed-article:9210039pubmed:meshHeadingpubmed-meshheading:9210039-...lld:pubmed
pubmed-article:9210039pubmed:meshHeadingpubmed-meshheading:9210039-...lld:pubmed
pubmed-article:9210039pubmed:meshHeadingpubmed-meshheading:9210039-...lld:pubmed
pubmed-article:9210039pubmed:meshHeadingpubmed-meshheading:9210039-...lld:pubmed
pubmed-article:9210039pubmed:meshHeadingpubmed-meshheading:9210039-...lld:pubmed
pubmed-article:9210039pubmed:meshHeadingpubmed-meshheading:9210039-...lld:pubmed
pubmed-article:9210039pubmed:meshHeadingpubmed-meshheading:9210039-...lld:pubmed
pubmed-article:9210039pubmed:meshHeadingpubmed-meshheading:9210039-...lld:pubmed
pubmed-article:9210039pubmed:meshHeadingpubmed-meshheading:9210039-...lld:pubmed
pubmed-article:9210039pubmed:meshHeadingpubmed-meshheading:9210039-...lld:pubmed
pubmed-article:9210039pubmed:meshHeadingpubmed-meshheading:9210039-...lld:pubmed
pubmed-article:9210039pubmed:meshHeadingpubmed-meshheading:9210039-...lld:pubmed
pubmed-article:9210039pubmed:year1997lld:pubmed
pubmed-article:9210039pubmed:articleTitleAmino-terminal epitopes are exposed when full-length open reading frame 2 of hepatitis E virus is expressed in Escherichia coli, but carboxy-terminal epitopes are masked.lld:pubmed
pubmed-article:9210039pubmed:affiliationMacfarlane Burnet Centre for Medical Research, Fairfield, Melbourne, Australia.lld:pubmed
pubmed-article:9210039pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9210039pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9210039lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9210039lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9210039lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9210039lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9210039lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9210039lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9210039lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9210039lld:pubmed